- Report
- March 2024
- 193 Pages
Global
From €3263EUR$3,374USD£2,763GBP
€3625EUR$3,749USD£3,070GBP
- Report
- September 2023
- 275 Pages
Global
From €5754EUR$5,950USD£4,873GBP
- Report
- April 2024
- 196 Pages
Global
From €4787EUR$4,950USD£4,054GBP
- Report
- February 2024
- 175 Pages
Global
From €4835EUR$5,000USD£4,095GBP
- Report
- November 2023
- 149 Pages
Global
From €2417EUR$2,499USD£2,047GBP
- Report
- January 2024
- 190 Pages
Global
From €4739EUR$4,900USD£4,013GBP
- Report
- January 2021
- 137 Pages
China, Global
From €3000EUR$3,323USD£2,630GBP
The Life Sciences BPO market within the context of Biotechnology is a rapidly growing sector that provides a range of services to biotechnology companies. These services include drug discovery and development, clinical trial management, regulatory affairs, and manufacturing. Life Sciences BPO companies provide expertise and resources to help biotechnology companies reduce costs, increase efficiency, and improve the quality of their products.
The Life Sciences BPO market is driven by the increasing demand for biotechnology products and services, as well as the need for cost-effective solutions. This market is expected to continue to grow as biotechnology companies look to outsource more of their operations.
Some of the major players in the Life Sciences BPO market include Parexel, Quintiles, ICON, Covance, and PPD. These companies provide a range of services to biotechnology companies, including drug discovery and development, clinical trial management, regulatory affairs, and manufacturing. Show Less Read more